Debant A - Search Results

1

Recurrent TRIO Fusion in Nontranslocation-Related Sarcomas.

Delespaul L, Lesluyes T, Pérot G, Brulard C, Lartigue L, Baud J, Lagarde P, Le Guellec S, Neuville A, Terrier P, Vince-Ranchère D, Schmidt S, Debant A, Coindre JM, Chibon F. Delespaul L, et al. Among authors: debant a. Clin Cancer Res. 2017 Feb 1;23(3):857-867. doi: 10.1158/1078-0432.CCR-16-0290. Epub 2016 Aug 15. Clin Cancer Res. 2017. PMID: 27528700

2

TrioGEF1 controls Rac- and Cdc42-dependent cell structures through the direct activation of rhoG.

Blangy A, Vignal E, Schmidt S, Debant A, Gauthier-Rouvière C, Fort P. Blangy A, et al. Among authors: debant a. J Cell Sci. 2000 Feb;113 ( Pt 4):729-39. doi: 10.1242/jcs.113.4.729. J Cell Sci. 2000. PMID: 10652265

3

Trio combines with dock to regulate Pak activity during photoreceptor axon pathfinding in Drosophila.

Newsome TP, Schmidt S, Dietzl G, Keleman K, Asling B, Debant A, Dickson BJ. Newsome TP, et al. Among authors: debant a. Cell. 2000 Apr 28;101(3):283-94. doi: 10.1016/s0092-8674(00)80838-7. Cell. 2000. PMID: 10847683 Free article.

4

The Human Rho-GEF trio and its target GTPase RhoG are involved in the NGF pathway, leading to neurite outgrowth.

Estrach S, Schmidt S, Diriong S, Penna A, Blangy A, Fort P, Debant A. Estrach S, et al. Among authors: debant a. Curr Biol. 2002 Feb 19;12(4):307-12. doi: 10.1016/s0960-9822(02)00658-9. Curr Biol. 2002. PMID: 11864571 Free article.

5

Identification of the first Rho-GEF inhibitor, TRIPalpha, which targets the RhoA-specific GEF domain of Trio.

Schmidt S, Diriong S, Méry J, Fabbrizio E, Debant A. Schmidt S, et al. Among authors: debant a. FEBS Lett. 2002 Jul 17;523(1-3):35-42. doi: 10.1016/s0014-5793(02)02928-9. FEBS Lett. 2002. PMID: 12123800 Free article.

6

Different regulation of the Trio Dbl-Homology domains by their associated PH domains.

Bellanger JM, Estrach S, Schmidt S, Briançon-Marjollet A, Zugasti O, Fromont S, Debant A. Bellanger JM, et al. Among authors: debant a. Biol Cell. 2003 Dec;95(9):625-34. doi: 10.1016/j.biolcel.2003.10.002. Biol Cell. 2003. PMID: 14720465

7

Identification of novel neuronal isoforms of the Rho-GEF Trio.

Portales-Casamar E, Briançon-Marjollet A, Fromont S, Triboulet R, Debant A. Portales-Casamar E, et al. Among authors: debant a. Biol Cell. 2006 Mar;98(3):183-93. doi: 10.1042/BC20050009. Biol Cell. 2006. PMID: 16033331

8

Identification of TRIO-GEFD1 chemical inhibitors using the yeast exchange assay.

Blangy A, Bouquier N, Gauthier-Rouvière C, Schmidt S, Debant A, Leonetti JP, Fort P. Blangy A, et al. Among authors: debant a. Biol Cell. 2006 Sep;98(9):511-22. doi: 10.1042/BC20060023. Biol Cell. 2006. PMID: 16686599 Free article.

9

Aptamer-derived peptides as potent inhibitors of the oncogenic RhoGEF Tgat.

Bouquier N, Fromont S, Zeeh JC, Auziol C, Larrousse P, Robert B, Zeghouf M, Cherfils J, Debant A, Schmidt S. Bouquier N, et al. Among authors: debant a. Chem Biol. 2009 Apr 24;16(4):391-400. doi: 10.1016/j.chembiol.2009.02.006. Chem Biol. 2009. PMID: 19389625 Free article.

10

Kidins220/ARMS regulates Rac1-dependent neurite outgrowth by direct interaction with the RhoGEF Trio.

Neubrand VE, Thomas C, Schmidt S, Debant A, Schiavo G. Neubrand VE, et al. Among authors: debant a. J Cell Sci. 2010 Jun 15;123(Pt 12):2111-23. doi: 10.1242/jcs.064055. J Cell Sci. 2010. PMID: 20519585 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

55 results

Search Page

Filters